Congress Asset Management Co. MA Sells 1,826 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

Congress Asset Management Co. MA decreased its position in Huron Consulting Group Inc. (NASDAQ:HURN) by 2.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 75,051 shares of the business services provider’s stock after selling 1,826 shares during the quarter. Congress Asset Management Co. MA owned about 0.41% of Huron Consulting Group worth $7,715,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in HURN. Semanteon Capital Management LP acquired a new stake in Huron Consulting Group in the 4th quarter worth approximately $1,166,000. Norges Bank acquired a new stake in Huron Consulting Group in the 4th quarter worth approximately $14,460,000. BNP Paribas Financial Markets lifted its holdings in Huron Consulting Group by 116.8% in the 4th quarter. BNP Paribas Financial Markets now owns 49,589 shares of the business services provider’s stock worth $5,098,000 after purchasing an additional 26,714 shares during the last quarter. Alpha DNA Investment Management LLC acquired a new stake in Huron Consulting Group in the 4th quarter worth approximately $482,000. Finally, CenterBook Partners LP lifted its holdings in Huron Consulting Group by 15.9% in the 4th quarter. CenterBook Partners LP now owns 10,805 shares of the business services provider’s stock worth $1,111,000 after purchasing an additional 1,485 shares during the last quarter. Institutional investors own 93.90% of the company’s stock.

Insider Buying and Selling at Huron Consulting Group

In other Huron Consulting Group news, Director John Mccartney sold 300 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $96.38, for a total value of $28,914.00. Following the transaction, the director now owns 56,619 shares of the company’s stock, valued at $5,456,939.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Huron Consulting Group news, Director James H. Roth sold 6,804 shares of the stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $95.00, for a total value of $646,380.00. Following the transaction, the director now owns 62,825 shares of the company’s stock, valued at $5,968,375. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director John Mccartney sold 300 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $96.38, for a total value of $28,914.00. Following the completion of the transaction, the director now directly owns 56,619 shares in the company, valued at approximately $5,456,939.22. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,963 shares of company stock valued at $849,095. 2.20% of the stock is currently owned by company insiders.

Huron Consulting Group Price Performance

Shares of HURN stock opened at $94.95 on Monday. The company has a debt-to-equity ratio of 1.13, a quick ratio of 2.40 and a current ratio of 2.40. Huron Consulting Group Inc. has a 52 week low of $77.99 and a 52 week high of $113.31. The stock has a market capitalization of $1.71 billion, a PE ratio of 27.36 and a beta of 0.59. The stock’s fifty day moving average is $90.57 and its 200-day moving average is $97.50.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings results on Tuesday, April 30th. The business services provider reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.88 by $0.35. Huron Consulting Group had a return on equity of 19.21% and a net margin of 4.67%. The business had revenue of $355.96 million for the quarter, compared to analyst estimates of $348.80 million. During the same quarter in the prior year, the firm posted $0.87 earnings per share. The firm’s revenue for the quarter was up 12.0% compared to the same quarter last year. Equities research analysts expect that Huron Consulting Group Inc. will post 5.83 EPS for the current fiscal year.

Wall Street Analyst Weigh In

HURN has been the subject of a number of research analyst reports. Truist Financial reiterated a “buy” rating and set a $140.00 price target on shares of Huron Consulting Group in a report on Thursday, May 16th. Barrington Research reiterated an “outperform” rating and set a $133.00 price target on shares of Huron Consulting Group in a report on Tuesday, May 28th. Wedbush reiterated an “outperform” rating and set a $110.00 price target on shares of Huron Consulting Group in a report on Thursday, May 23rd. StockNews.com lowered Huron Consulting Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 28th. Finally, Benchmark reiterated a “buy” rating and set a $140.00 price target on shares of Huron Consulting Group in a report on Monday, May 13th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $130.75.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.